树突状细胞与肿瘤免疫及其肿瘤生物治疗应用
被引量:3
Dendritic Cells in Tumor Immunity and its Application in Biological Therapy for Tumor
摘要
全文主要对树突状细胞(DC)的来源及生物学特征、DC参与抗肿瘤的机制、DC与肿瘤免疫逃逸的关系及DC在肿瘤生物治疗中的应用作一综述。
出处
《肿瘤学杂志》
CAS
2005年第2期131-133,共3页
Journal of Chinese Oncology
基金
广西医疗卫生重点科研课题(编号:重200311)
参考文献17
-
1张红梅,任军,张利旺,张亮,张燕军,斯晓明,范黎,潘伯荣.外周血造血干细胞体外定向诱导树突状细胞及功能鉴定[J].第四军医大学学报,2003,24(1):83-85. 被引量:12
-
2Hieshima K, Imai T, Baba M, et al. A novel human CC chemokine PARC that is most homologous to macrophageinflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes [J]. J Immunol, 1997,159(3):1140-1149.
-
3Andersen DM, Marskovsky E, Billingskev WL, et al. A homologue of the TNF receptor and its ligand enhance Tcell growth and dendritic cell function [J]. Nature, 1997,390(6656):175-179.
-
4Furnmoto K, Mon A, Yamasaki S, et al. Interleukin-12-gene transduction make DCs from tumor-bearing mice an effective inducer of tumor-specific immunity in a peritoneal mode [J]. Immunol Lett, 2002,83(1):13-20.
-
5Hart DNJ. Dendritic cells: Unique leukocyte populations with control the primary immune response [J]. Blood,1997,90:3245-3287.
-
6Tgarte K, Klein B. Dendritic cell-based vaccine: a promising approach for cancer immunotherapy [J]. Blood Reviews, 1999,13:51-64.
-
7Pirtskhalaishvili G, Shurin G, Gambotto A, et al. Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apotptosis and antitumor effect in mice [J]. J Immunol, 2000, 165(4):1956-1961.
-
8王宝成,郭军.树突状细胞肿瘤免疫治疗临床应用进展[J].中国肿瘤生物治疗杂志,2002,9(1):68-71. 被引量:7
-
9Andersen MH, Keikavoussi P, Brocker EB, et al. Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses associated with disease progression [J]. Int J Cancer, 2001,194(6):820-824.
-
10Storkus WJ, Zeh H J, Salter RD, et al. Identification of T cell epitopes: rapid isolation of class Ⅰ presented peptides from viable cells by mild acid elution [J]. J Immunolther, 1998,14:94-99.
二级参考文献33
-
1[17]Liso A,Stockerl-Goldstein KE,Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell tnmsplentation for multiple myeloma[J].Biol Blood Marrow Transplant,2000,6(6): 621-627.
-
2[18]Brossart P,Wirths S,Stuhler G,et al.Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells[J].Blood,2000,96(9): 3102-3108.
-
3[19]Yu JS,Wheeler CJ,Zeltzer PM,et al.Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intraeranial T-cell infiltration[J].Cancer Res,2001,61(3): 842-847.
-
4[20]Morse MA,Nalr S,Femandez-Casal M,et al.Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer[J].J Clin Oncol,2000,18 (23): 3883-3893.
-
5[21]Okada H,Pollack IF,Lieberman F,et al.Gene therapy of malignant gliomas: A pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response[J].Hum Gene Ther,2001 ,12(5): 575-595.
-
6[22]Panelli MC,Wunderlich J,Jeffries J,et al.Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100[J].J Immunother,2000,23(4): 487-498.
-
7[23]Simmons SJ,Tjoa BA,Rogers M,et al.GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial[ J].Prostate,1999,39(4): 291-297.
-
8[24]Schuler-Thurner B,Dieckmann D,Keikavoussi P,et al.Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1 + melanoma patients by mature monocytederived dendritic cells[J].J Immunol ,2000,165(6): 3492-3496.
-
9[25]Hart I,Colaco C.Immunotherapy.Fusion induces tumour rejection[J].Nature,1997,388: 626-627.
-
10[26]Gong J,Avigan D,Chen D,et al.Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells[J].Proc Nail Acad Sci USA,2000,97: 2715-2718.
共引文献26
-
1于哲,范清宇,张婷,刘云燕.大鼠骨髓造血干细胞体外定向诱导、扩增树突状细胞及其功能鉴定[J].医学研究生学报,2004,17(7):588-591. 被引量:10
-
2杨静悦,任军,白俊,刘都户,范黎,斯小明,腾增辉,杨文涛.HBsAg基因修饰的树突状细胞体外诱导抗HepG2.2.15特异性细胞毒作用[J].癌症,2004,23(8):914-917. 被引量:2
-
3于哲,范清宇,马保安,郝新保,龙华.大鼠树突状细胞融合瘤苗的特异性抗骨肉瘤作用[J].癌症,2005,24(3):285-291. 被引量:5
-
4尹礼烘,王慧民,赵凤达.前列腺癌的免疫治疗研究进展[J].实用癌症杂志,2004,19(5):550-551. 被引量:1
-
5贾军,任军,张利旺,张红梅,郭晓彤,斯晓明,王九花,程婕.AFP基因转染CD34^+造血干细胞来源的树突状细胞诱导特异性抗肝癌免疫[J].第四军医大学学报,2005,26(8):755-757. 被引量:3
-
6韩超峰,曹雪涛.肿瘤诱导的树突状细胞功能缺陷及其机制[J].中国肿瘤生物治疗杂志,2005,12(2):89-93. 被引量:12
-
7周娟,徐立春.树突状细胞和肿瘤免疫治疗研究进展[J].实用肿瘤学杂志,2006,20(2):146-150. 被引量:2
-
8张利旺,张红梅,刘文超,潘伯荣,斯晓明,任军.以GFP为标记的肝癌细胞RNA转染树突状细胞的体外效应[J].第四军医大学学报,2006,27(11):1046-1048.
-
9葛莲英.树突状细胞与肿瘤免疫及其在肿瘤生物治疗中的应用[J].中国医学文摘(肿瘤学),2006,20(3):261-263. 被引量:3
-
10谢遵江,贺业春,贾立敏,郑金华,刘颖,刘丽,张亿倬.树突状细胞在S-180肉瘤模型鼠体内的分布和细胞间黏附分子-1等因子的表达[J].解剖学报,2006,37(5):530-534.
同被引文献50
-
1汪灏,余佩武,郝群,曾冬竹,张坤,王月禾,雷晓,饶芸,蔡志民.树突状细胞疫苗对胃癌患者术后免疫功能影响的初步观察[J].中华胃肠外科杂志,2004,7(4):301-304. 被引量:4
-
2钟华,韩宝惠,董强刚,冯久贤,包国良,沙慧芳,苏建中.肺癌胸腔积液中树突状细胞的诱导培养及功能分析[J].中华结核和呼吸杂志,2004,27(8):542-545. 被引量:7
-
3黄慧,曾波航,陈静琦,吕嘉春.恶性胸腔积液来源树突状细胞的纯化培养研究[J].肿瘤学杂志,2005,11(2):99-102. 被引量:4
-
4杨杨,王宏伟.自身免疫病与树突状细胞免疫调控[J].中华风湿病学杂志,2006,10(2):108-110. 被引量:1
-
5贾建军,王自能.树突状细胞与抗肿瘤免疫[J].中国优生与遗传杂志,2006,14(11):128-130. 被引量:2
-
6Banchereau J, steinman R. Dendritic cells and the control of immunity[J]. Nature(Lond), 1998, 392:245 - 252.
-
7Gjomarkaj M, Pace E, Melis M, et al. Dendritic cells with a potent accessory activity are present in human exudative malignant pleural effusions[J]. Eur Respir J, 1997, 10(3) :592 - 597.
-
8MinWP, Zhou DJ, Ichim TE, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cell in transplant tolerance [J] .J Immunol, 2003, 107:1304 - 1312.
-
9Fong L, Brockstedt D, Benike C, et al. Dendritic cell - based xenoanti gen vaccination for prostate cancer immunotherapy[J ]. J immunol, 2001,167 : 7150 - 7156.
-
10Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B - cell lymphoma using autologous antigen Pulsed dendritic cells [J]. Nat Med, 1996, 2(1):52 - 58.
引证文献3
-
1马樱,李阳亮.树突状细胞与肿瘤免疫治疗新进展[J].基层医学论坛,2006,10(10):934-935. 被引量:4
-
2李瑞霞,苏秀兰,李国华,付秀华.肺癌胸腔积液中树突状细胞的研究[J].内蒙古医学杂志,2008,40(3):264-266.
-
3刘晓玲,宋振川.树突状细胞肿瘤免疫研究进展[J].肿瘤学杂志,2012,18(11):870-874. 被引量:2
二级引证文献6
-
1孙玲,任渝江,袁丽佳.树突状细胞与肿瘤免疫治疗[J].西南军医,2007,9(6):93-94.
-
2刘文佳,邹晓平,曹俊.树突状细胞胰腺癌免疫治疗新进展[J].中华消化杂志,2008,28(8):575-576. 被引量:1
-
3李志伟,杨守芳.非特异性免疫治疗消化道肿瘤临床分析[J].中国现代药物应用,2011,5(8):38-39. 被引量:1
-
4肖永双(综述),温儒民(审校).树突状细胞在肾癌免疫治疗中的作用[J].徐州医学院学报,2011,31(5):360-362.
-
5申育萌,赵姗姗,杨倩.猪扁桃体中树突状细胞的分布研究[J].南京农业大学学报,2014,37(6):125-129. 被引量:1
-
6陈文娜,王俊岩,贾连群,丛培玮,孙宏伟.牛膝有效部位在肿瘤微环境下促进树突状细胞成熟及功能调控的研究[J].中国药学杂志,2015,50(23):2051-2056. 被引量:18
-
1吴刚军.树突细胞为基础的肿瘤免疫治疗策略[J].实用医学杂志,1999,15(3):230-232. 被引量:1
-
2鲍镇美.肾癌的生物治疗[J].实用肿瘤杂志,2000,15(1):7-8. 被引量:12
-
3彭瑞元,邹桂华.膀胱移行细胞癌内树突细胞的分布与临床预后的关系[J].中华医学杂志,1991,71(1):579-580. 被引量:7
-
4李殿俊.肿瘤生物治疗的研究现状及其在国内的应用(摘要)[J].中国肿瘤,1997,6(3):11-12. 被引量:1
-
5王桂林,荀雅书,李彩平.肿瘤生物治疗的研究[J].内蒙古科技与经济,2000(1):64-64.
-
6顾健人.论肿瘤生物治疗研究中的若干问题[J].中华医学杂志,1996,76(9):643-643. 被引量:2
-
7王伟,张杰.晚期肾癌免疫治疗新进展[J].世界临床药物,2014,35(2):65-68. 被引量:2
-
8李文斌,陈慧媛.胶质瘤的免疫治疗[J].中国微侵袭神经外科杂志,2009,14(10):478-480. 被引量:1
-
9张玉勤.炎症与癌症[J].国外医学情报,2002,23(1):12-17. 被引量:6
-
10肝、胆[J].中国癌症防治杂志,1998(1):40-51.